这位协和专家，要让宫颈癌从中国消失
Ranking
No observed public metrics; popularity remains neutral/archived.
Merged summary
TL;DR - A profile of public-health expert Qiao Youlin traces nearly three decades of work expanding cervical-cancer prevention in China through HPV testing, vaccination, and low-cost screening. His efforts helped inform national programs, including HPV vaccine coverage for 13-year-old girls, while highlighting screening access as the remaining major gap.
- Large-scale Chinese research found a 14.2% high-risk HPV infection rate and reported 95.2% detection of cervical cancer and precancerous lesions using HPV testing.
- Qiao’s team developed careHPV, a portable rapid-screening system for low-resource regions that received WHO prequalification and has been deployed internationally.
- Local free-vaccination pilots beginning in Ordos in 2020 helped catalyze broader adoption and the HPV vaccine’s inclusion in China’s national immunization program.
- China’s hardest remaining WHO “90-70-90” challenge is screening 70% of eligible women, motivating efforts to make testing cheaper, more accessible, and capable of returning results within 30 minutes.
Sources (1)
这位协和专家，要让宫颈癌从中国消失
TL;DR - A profile of public-health expert Qiao Youlin traces nearly three decades of work expanding cervical-cancer prevention in China through HPV testing, vaccination, and low-cost screening. His efforts helped inform national programs, including HPV vaccine coverage for 13-year-old girls, while highlighting screening access as the remaining major gap.
- Large-scale Chinese research found a 14.2% high-risk HPV infection rate and reported 95.2% detection of cervical cancer and precancerous lesions using HPV testing.
- Qiao’s team developed careHPV, a portable rapid-screening system for low-resource regions that received WHO prequalification and has been deployed internationally.
- Local free-vaccination pilots beginning in Ordos in 2020 helped catalyze broader adoption and the HPV vaccine’s inclusion in China’s national immunization program.
- China’s hardest remaining WHO “90-70-90” challenge is screening 70% of eligible women, motivating efforts to make testing cheaper, more accessible, and capable of returning results within 30 minutes.